Sekisui Jushi (4212) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
11 Mar, 2026Executive summary
Net sales for the six months ended September 30, 2025, rose 5.9% year-over-year to ¥34,992 million, with operating profit up 26.4% to ¥1,735 million and profit attributable to owners of parent up 39.2% to ¥1,118 million, driven by the consolidation of RIKEN KOGYO and steady performance in existing businesses.
Comprehensive income decreased 35.3% year-over-year to ¥1,962 million for the period.
Full-year forecast remains unchanged, with expectations of continued growth despite market uncertainties.
Financial highlights
Interim net sales: ¥34,992 million, up 5.9% year-over-year.
Operating profit: ¥1,735 million, up 26.4% year-over-year.
Ordinary profit: ¥2,005 million, up 26.2% year-over-year.
Profit attributable to owners of parent: ¥1,118 million, up 39.2% year-over-year.
EBITDA: ¥3,618 million, up 17.0% year-over-year.
Outlook and guidance
Full-year net sales forecast: ¥79,000 million, up 6.4% year-over-year.
Operating profit forecast: ¥6,400 million, up 27.7% year-over-year.
Ordinary profit forecast: ¥6,700 million, up 23.0% year-over-year.
Profit attributable to owners of parent forecast: ¥4,300 million, up 21.3% year-over-year.
Basic EPS forecast: ¥141.40.
Latest events from Sekisui Jushi
- Sales rose on M&A gains, but profits fell; 2H outlook and shareholder returns remain strong.4212
Q2 202511 Mar 2026 - Sales up 18.2% YoY, profit down on higher costs; profit growth and higher dividends expected.4212
Q4 202511 Mar 2026 - Sales up 19.5% YoY, but profits fell on higher costs; outlook and dividend growth maintained.4212
Q3 202511 Mar 2026 - Sales and profits increased, with strong outlook and share buyback supporting EPS growth.4212
Q1 202611 Mar 2026 - Sales and profits surged, dividend and share buyback completed, outlook remains strong.4212
Q3 202611 Mar 2026 - Sales rose but profits fell on higher costs; full-year outlook remains positive.4212
Q1 202511 Mar 2026